Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods, Inc. (NASDAQ: LWAY) is a U.S. manufacturer of probiotic, cultured and fermented dairy foods best known for its drinkable kefir, cheeses and ProBugs products for kids. This news page aggregates coverage of the company’s announcements, regulatory disclosures and shareholder communications so readers can follow developments affecting the LWAY stock and the underlying business.
Company news releases highlight Lifeway’s role as America’s leading supplier of the probiotic, fermented beverage known as kefir and as a leading U.S. supplier of kefir and fermented probiotic foods. Recent items include product innovation such as the planned launch of Probiotic Kefir Butter™, which extends the company’s cultured dairy expertise into spreadable European-style butter, as well as updates on sales trends and volume growth for its kefir portfolio.
Investors can also find governance and capital markets news, including details of a Cooperation Agreement with Danone North America PBC, board refreshment steps, amendments to a shareholder rights plan and proxy-related communications involving Institutional Shareholder Services and significant shareholders. These stories provide context on how Lifeway’s board structure, shareholder base and strategic options are evolving.
In addition, Lifeway’s news flow covers participation in investor conferences, commentary on federal dietary guidelines that reference kefir and fermented foods, and other corporate updates. By reviewing this page, readers can see how product initiatives, governance developments and financial disclosures intersect for Lifeway Foods, Inc. and its LWAY listing on the Nasdaq Global Market.
Lifeway Foods (LWAY) is launching a charity relief bottle, directing 100% of profits, up to $1 million, to support humanitarian aid for Ukraine. This initiative builds on their ongoing efforts, including a fundraiser that raised $700,000 for World Central Kitchen. Lifeway’s Plain Whole Milk Kefir will be the flagship product, expected on shelves in June. The company emphasizes its commitment to humanitarian support and collaboration with various organizations to aid Ukraine, reflecting its Ukrainian heritage and mission to help those in need.
Lifeway Foods (Nasdaq: LWAY) announced the filing of preliminary proxy materials for its 2022 Annual Meeting of Shareholders, revealing a slate of director nominees. The board proposes adding independent nominees, Perfecto Sanchez and JC Dalto, to enhance its leadership. CEO Julie Smolyansky highlighted their industry expertise and potential to add value. Lifeway's ongoing strategy has led to eight consecutive quarters of sales growth, with new product innovations like Lifeway Oat boosting retail acceptance. The company is committed to maintaining a diverse and skilled board for sustainable growth.
Lifeway Foods, Inc. (Nasdaq: LWAY) received a Nasdaq Notice dated April 19, 2022, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The Company is required to submit a compliance plan within 60 days of the notice. If accepted, Nasdaq may grant an extension of up to 180 days to regain compliance. Lifeway is actively working to file the Form 10-K as soon as possible.
Lifeway Foods, Inc. (LWAY) will present its new probiotic oat beverages at the Natural Products Expo West 2022 from March 8-12 in Anaheim, CA. Featured products include the Lifeway Organic Oat, a NEXTY Award finalist, and the Lifeway MSHRM Oat™, an adaptogenic mushroom drink. Attendees can sample various flavors and learn about the health benefits of probiotics. CEO Julie Smolyansky emphasizes the company’s commitment to supporting gut health and immunity, especially as mental health is a growing concern.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced a supportive response to a recent 13D filing, affirming CEO Julie Smolyansky's ongoing leadership and execution of the Lifeway 2.0 strategy. The independent Directors highlighted a track record of growth, marking eight consecutive quarters of year-over-year net sales increases. New product innovations, including the launch of Lifeway Oat and the acquisition of GlenOaks Farms for yogurt production, are expected to drive future growth. The Board remains committed to enhancing long-term shareholder value.
Lifeway Foods (Nasdaq: LWAY) announced its participation in the Winter Fancy Food Show from February 6-8, 2022, showcasing its new Lifeway MSHRM Oat™ line of adaptogenic functional mushroom beverages. The products feature 10 probiotics and are available in three flavors: Calm (Reishi), Support (Mushroom Immune Blend), and Focus (Lion's Mane). The global functional mushroom market is projected to reach $19.33 billion by 2033, highlighting rising consumer interest in health-oriented products. Lifeway aims to meet demand for innovative beverages at this event.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced projected unaudited net revenues for fiscal year 2021 between $117 million and $118.5 million, ending December 31, 2021. CEO Julie Smolyansky will participate in the ICR Conference from January 10-12, 2022, with a presentation scheduled for January 11 at 10:00 AM ET. Lifeway is recognized as a leading U.S. supplier of kefir and probiotic products, with offerings available in multiple countries including the U.S., Mexico, and the UK.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced a recent review highlighting the role of kefir in combating oxidative stress and inflammation linked to chronic neurodegenerative diseases like Parkinson’s and Alzheimer’s.
The review detailed how kefir's probiotics may slow disease progression and improve gut health. Key findings included the association of neurodegeneration with inflammation and the potential neuroprotective effects of kefir on the microbiota.
Lifeway is encouraged by these findings as they position kefir as a viable therapeutic option for millions affected by these diseases.
Lifeway Foods reported third-quarter net sales of $29.6 million, marking a 13.5% increase year-over-year and maintaining its eighth consecutive quarter of growth. The rise was largely attributed to higher sales volumes of branded drinking kefir and the acquisition of GlenOaks Farms. The company remains confident in managing its supply chain, boosting lead times to vendors. Lifeway also introduced new products, including Lifeway Oat, a dairy-free drink, and anticipates strong demand during the holiday season with prepared inventory.
Summary not available.
FAQ
What is the current stock price of Lifeway Food (LWAY)?
What is the market cap of Lifeway Food (LWAY)?
